iGlarLixi reduces residual hyperglycemia in Japanese patients with type 2 diabetes uncontrolled on basal insulin: A post‐hoc analysis of the LixiLan JP‐L trial.
| Autor: | Yabe, Daisuke1,2,3 (AUTHOR) ydaisuke-kyoto@umin.ac.jp, Iizuka, Katsumi1,4 (AUTHOR), Baxter, Mike5,6 (AUTHOR), Watanabe, Daisuke7 (AUTHOR), Kaneto, Hideaki8 (AUTHOR) |
|---|---|
| Zdroj: | Journal of Diabetes Investigation. Nov2021, Vol. 12 Issue 11, p1992-2001. 10p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|